JW Pharmaceutical Corp Working Capital to Net Assets Ratio
JW Pharmaceutical Corp working capital to net assets ratio. JW Pharmaceutical Corp (001065) has a Working Capital to Net Assets ratio of 30.2% as of June 2026. Working capital of ₩123.86 Billion (current assets of ₩344.50 Billion minus current liabilities of ₩220.64 Billion) is measured against net assets of ₩409.94 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of JW Pharmaceutical Corp to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of JW Pharmaceutical Corp (2014–2025)
Working capital to net assets ratio of JW Pharmaceutical Corp from 2014 to 2025. This chart shows how JW Pharmaceutical Corp's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2014 to 2025. As of June 2026, the ratio stands at 30.2%, reflecting working capital of ₩123.86 Billion against net assets of ₩409.94 Billion KRW. See 001065 days of operational coverage to measure how many days the company can operate on defensive assets alone.
JW Pharmaceutical Corp Working Capital to Net Assets Ratio by Year (2014–2025)
JW Pharmaceutical Corp working capital to net assets ratio by year from 2014 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for JW Pharmaceutical Corp from 2014 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see how large is JW Pharmaceutical Corp's balance sheet.
| Year | WC/NA Ratio | Working Capital (KRW) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 23.6% | ₩87.35 Billion | ₩369.37 Billion | ₩296.51 Billion | ₩209.16 Billion | ▼ -6.0 pp |
| 2024 | 29.7% | ₩97.80 Billion | ₩329.49 Billion | ₩306.41 Billion | ₩208.62 Billion | ▼ -4.7 pp |
| 2023 | 34.3% | ₩91.16 Billion | ₩265.44 Billion | ₩378.09 Billion | ₩286.93 Billion | ▲ +14.3 pp |
| 2022 | 20.1% | ₩45.33 Billion | ₩225.76 Billion | ₩425.46 Billion | ₩380.13 Billion | ▼ -24.4 pp |
| 2021 | 44.4% | ₩83.77 Billion | ₩188.54 Billion | ₩366.45 Billion | ₩282.68 Billion | ▲ +13.3 pp |
| 2020 | 31.1% | ₩64.58 Billion | ₩207.47 Billion | ₩299.33 Billion | ₩234.75 Billion | ▲ +6.3 pp |
| 2019 | 24.8% | ₩57.07 Billion | ₩230.09 Billion | ₩335.06 Billion | ₩277.98 Billion | ▼ -31.1 pp |
| 2018 | 56.0% | ₩145.54 Billion | ₩260.11 Billion | ₩373.91 Billion | ₩228.37 Billion | ▲ +5.4 pp |
| 2017 | 50.5% | ₩136.83 Billion | ₩270.78 Billion | ₩411.37 Billion | ₩274.54 Billion | ▼ -9.1 pp |
| 2016 | 59.6% | ₩164.67 Billion | ₩276.31 Billion | ₩422.64 Billion | ₩257.98 Billion | ▲ +8.4 pp |
| 2015 | 51.2% | ₩115.39 Billion | ₩225.41 Billion | ₩376.17 Billion | ₩260.78 Billion | ▼ -8.8 pp |
| 2014 | 60.0% | ₩132.06 Billion | ₩220.02 Billion | ₩343.50 Billion | ₩211.44 Billion | — |